ChineseChina UKUK DeutschlandDeutschland FranceFrance РоссияРоссия 한국한국 ไทยไทย Việt NamViệt Nam العربيةالعربية ҚазақстанҚазақстан EspañaEspaña MyanmarMyanmar DaiDai

Linking China’s Premium Healthcare · Serving Global Health Needs

Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties

One-Stop Medical Care in China

  • International flights · Airport pickup · Nearby hotels
  • Multilingual interpreters · Full medical escort
  • Expert matching · Hospital fast-track
  • Full-cycle treatment · Post-op follow-up
Sign in

Mr. George - hypoglycemia

Patient basic information Patient: Mr. George (George Thompson) Nationality: Italy Diagnosis: Diabetes mellitus Accumulation Hospital: H0O treatment: Insulination treatment + medication Holidays: 148 days Treatment cost: about 474211 yuan Treatment effect: Complete mitigation The condition is described by Mr. George from Italy, who was diagnosed with Diabetes mellitus locally.

Upon arrival, the International Medical Services Team arranged for the first time multidisciplinary MDT clinics for patients, developed individualized clinical pathways based on patient inspection reports and physical conditions, and provided translation, guidance and on-site services throughout the treatment process. After 148 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and the test indicators returned to normal areas and successfully reached the hospital standard. The patient's treatment effects were finally completely alleviated.

When he left the hospital, the medical team developed a detailed return follow-up and rehabilitation plan for him, and continued to track recovery through the remote follow-up system. 'Mr. Liu George criticized the case as a typical case of cross-border suspected seriousness clinical disease.

Liu 4 relies on a multidisciplinary collaborative mechanism to develop an intracellular treatment + drug program for hypoglycemia, which reflects the comprehensive strength of Chinese hospitals in the field of suspected disease clinics, and a summary of how international medical services are regulated. (Figure from Liu 5 official news reports and medical scenarios)

意大利,黏多糖贮积症,北京宣武医院,国际医疗,来华就医,中国医疗